Silvercrest Asset Management’s Pacira BioSciences PCRX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-122,854
| Closed | -$4.92M | – | 855 |
|
|
2023
Q2 | $4.92M | Buy |
122,854
+18,596
| +18% | +$745K | 0.04% | 372 |
|
|
2023
Q1 | $4.25M | Sell |
104,258
-113
| -0.1% | -$4.61K | 0.03% | 377 |
|
|
2022
Q4 | $4.03M | Sell |
104,371
-171,080
| -62% | -$6.61M | 0.03% | 373 |
|
|
2022
Q3 | $14.7M | Sell |
275,451
-14,859
| -5% | -$790K | 0.12% | 186 |
|
|
2022
Q2 | $16.9M | Sell |
290,310
-7,926
| -3% | -$462K | 0.13% | 184 |
|
|
2022
Q1 | $22.8M | Sell |
298,236
-56,370
| -16% | -$4.3M | 0.15% | 173 |
|
|
2021
Q4 | $21.3M | Buy |
354,606
+78,559
| +28% | +$4.73M | 0.14% | 172 |
|
|
2021
Q3 | $15.5M | Sell |
276,047
-16,509
| -6% | -$925K | 0.1% | 203 |
|
|
2021
Q2 | $17.8M | Sell |
292,556
-20,288
| -6% | -$1.23M | 0.12% | 198 |
|
|
2021
Q1 | $21.9M | Sell |
312,844
-108,123
| -26% | -$7.58M | 0.15% | 174 |
|
|
2020
Q4 | $25.2M | Buy |
420,967
+21,648
| +5% | +$1.3M | 0.18% | 148 |
|
|
2020
Q3 | $24M | Buy |
399,319
+200,871
| +101% | +$12.1M | 0.21% | 134 |
|
|
2020
Q2 | $10.4M | Sell |
198,448
-3,533
| -2% | -$185K | 0.09% | 206 |
|
|
2020
Q1 | $6.77M | Buy |
201,981
+24,783
| +14% | +$831K | 0.07% | 232 |
|
|
2019
Q4 | $8.03M | Sell |
177,198
-7,522
| -4% | -$341K | 0.06% | 257 |
|
|
2019
Q3 | $7.03M | Buy |
+184,720
| New | +$7.03M | 0.06% | 260 |
|